Privi Speciality Che

₹1134 -22.4 | 1.9%

WEBSITE BSE:530117 NSE : PRIVISCL 10 May, 16:01

Market Cap ₹4430 Cr.

Stock P/E 46.7

P/B 4.8

Current Price ₹1134

Book Value ₹ 236.6

Face Value 10

52W High ₹1373.5

Dividend Yield 0%

52W Low ₹ 975

Edit Ratio

Privi Speciality Che Research see more...

Overview Inc. Year: 1985Industry: Chemicals

Privi Speciality Chemicals Ltd, formerly known as Fairchem Speciality Ltd, is an totally India-based agency engaged within the business of producing of speciality chemicals. The Company manufactures oleo chemicals, aroma chemical substances and intermediate neutraceuticals. The Company manufactures products, such as linoleic acid, dimer acid and monomer acid, herbal blended tocopherol concentrate and concentrated sterols. The Company's oleo chemicals are utilized in diverse industries, which includes paints, inks, soaps, amines and adhesives. Its neutraceuticals comprises herbal focused tocopherols and natural focused sterols. Its aroma chemical compounds include violetone coeur, tetrahydrogeranyl acetate, sandal fleur laevo, nimberol, Indian sandal center, florascone and citronellyl acetate.

Privi Speciality Che Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Privi Speciality Che Quarterly Results

#(Fig in Cr.)	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	395	377	389	400	420	399	409	455	404	484
Other Income	11	9	4	9	6	3	6	7	6	8
Total Income	405	386	392	409	426	402	415	462	409	492
Total Expenditure	345	329	330	357	368	367	354	366	314	393
Operating Profit	60	56	62	52	58	35	61	96	96	99
Interest	6	8	10	15	20	23	24	25	24	25
Depreciation	18	20	22	26	30	31	31	31	32	30
Exceptional Income / Expenses	-2	13	0	0	0	0	0	0	0	0
Profit Before Tax	34	41	30	11	8	-19	6	40	39	44
Provision for Tax	9	11	8	3	3	-4	2	10	10	12
Profit After Tax	25	30	22	8	6	-15	5	30	29	32
Adjustments	0	0	-0	-0	-0	1	0	0	-0	-1
Profit After Adjustments	25	30	22	8	6	-14	5	31	29	31
Adjusted Earnings Per Share	6.4	7.7	5.7	2	1.4	-3.5	1.2	7.8	7.4	7.9

Privi Speciality Che Profit & Loss

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	597	1024	1341	1324	1277	1404	1608	1752
Other Income	10	16	6	26	20	32	21	27
Total Income	608	1040	1347	1350	1297	1436	1629	1778
Total Expenditure	525	894	1128	1104	1067	1209	1420	1427
Operating Profit	82	146	218	247	230	227	209	352
Interest	20	24	29	38	24	25	70	98
Depreciation	27	43	47	57	71	75	108	124
Exceptional Income / Expenses	0	0	9	40	23	5	0	0
Profit Before Tax	36	79	152	193	158	133	31	129
Provision for Tax	8	26	57	47	41	35	10	34
Profit After Tax	27	53	94	146	117	97	21	96
Adjustments	0	0	0	0	0	0	1	-1
Profit After Adjustments	27	53	94	146	117	97	22	96
Adjusted Earnings Per Share	7.2	14.2	24.1	37.4	29.9	24.9	5.7	24.3

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	15%	7%	9%	0%
Operating Profit CAGR	-8%	-5%	7%	0%
PAT CAGR	-78%	-48%	-17%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	0%	2%	18%	24%
ROE Average	3%	11%	15%	13%
ROCE Average	6%	11%	14%	13%

Privi Speciality Che Balance Sheet

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	444	488	576	612	723	812	829
Minority's Interest	0	0	0	0	0	7	6
Borrowings	66	77	181	226	332	381	404
Other Non-Current Liabilities	25	31	39	33	32	47	51
Total Current Liabilities	403	457	630	513	454	929	1101
Total Liabilities	939	1053	1426	1384	1540	2176	2391
Fixed Assets	388	435	498	598	598	704	1017
Other Non-Current Assets	67	77	127	58	242	419	172
Total Current Assets	485	541	801	728	700	1053	1202
Total Assets	939	1053	1426	1384	1540	2176	2391

Privi Speciality Che Cash Flow

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	0	12	16	85	15	33
Cash Flow from Operating Activities	17	107	21	216	149	5	49
Cash Flow from Investing Activities	-67	-81	-139	-176	-242	-320	-133
Cash Flow from Financing Activities	-89	-20	122	28	23	333	72
Net Cash Inflow / Outflow	-140	5	4	68	-69	17	-12
Closing Cash & Cash Equivalent	7	12	16	85	15	33	20

Privi Speciality Che Ratios

#	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	7.21	14.19	24.13	37.38	29.93	24.93	5.69
CEPS(Rs)	14.34	25.7	36.12	51.92	48.1	44.04	33.22
DPS(Rs)	1	1.5	2.5	1.5	2	2	0
Book NAV/Share(Rs)	117.7	129.47	147.37	156.68	184.96	207.8	212.24
Core EBITDA Margin(%)	11.31	12.48	15.68	16.63	16.42	13.88	11.67
EBIT Margin(%)	8.72	9.86	13.31	17.36	14.23	11.25	6.26
Pre Tax Margin(%)	5.59	7.57	11.17	14.52	12.38	9.45	1.93
PAT Margin (%)	4.26	5.11	6.95	11.01	9.15	6.93	1.32
Cash Profit Margin (%)	8.48	9.26	10.4	15.29	14.7	12.25	8.07
ROA(%)	2.89	5.36	7.6	10.4	8	5.24	0.93
ROE(%)	6.13	11.48	17.74	24.59	17.52	12.69	2.59
ROCE(%)	7.25	13	19.17	21.11	15.36	10.64	5.58
Receivable days	99.76	70.7	75.49	77.01	66.81	65.48	63.62
Inventory Days	141.22	83.95	80.47	95.36	95.83	124.57	160.66
Payable days	115.18	76.27	81.89	84.18	78.85	107.03	116.54
PER(x)	75.96	26.57	19.21	11.17	28.34	75.35	184.75
Price/Book(x)	4.65	2.91	3.14	2.66	4.58	9.04	4.95
Dividend Yield(%)	0.18	0.4	0.54	0.36	0.24	0.11	0
EV/Net Sales(x)	3.94	1.68	1.7	1.54	3	5.85	3.19
EV/Core EBITDA(x)	28.57	11.8	10.43	8.28	16.64	36.09	24.56
Net Sales Growth(%)	0	71.49	30.92	-1.26	-3.59	9.96	14.54
EBIT Growth(%)	0	85.41	75.49	27.48	-20.98	-13.11	-36.35
PAT Growth(%)	0	96.69	76.65	54.95	-19.95	-16.7	-78.15
EPS Growth(%)	0	96.69	70.08	54.95	-19.95	-16.7	-77.19
Debt/Equity(x)	0.72	0.67	0.85	0.82	0.73	1.12	1.27
Current Ratio(x)	1.2	1.18	1.27	1.42	1.54	1.13	1.09
Quick Ratio(x)	0.59	0.67	0.69	0.78	0.79	0.47	0.37
Interest Cover(x)	2.78	4.3	6.22	6.13	7.68	6.25	1.45
Total Debt/Mcap(x)	0.16	0.23	0.27	0.31	0.16	0.12	0.26

Privi Speciality Che Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	74.06	74.05	74.05	74.05	74.05	74.05	74.05	74.05	74.05	74.05
FII	0.24	0.51	0.53	0.46	0.57	0.9	0.99	0.97	0.96	0.62
DII	3.39	3.66	3.56	3.61	3.6	3.74	3.53	3.37	3.4	3.37
Public	22.3	21.79	21.87	21.88	21.79	21.31	21.43	21.61	21.6	21.95
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	2.89	2.89	2.89	2.89	2.89	2.89	2.89	2.89	2.89	2.89
FII	0.01	0.02	0.02	0.02	0.02	0.04	0.04	0.04	0.04	0.02
DII	0.13	0.14	0.14	0.14	0.14	0.15	0.14	0.13	0.13	0.13
Public	0.87	0.85	0.85	0.85	0.85	0.83	0.84	0.84	0.84	0.86
Others	0	0	0	0	0	0	0	0	0	0
Total	3.91	3.91	3.91	3.91	3.91	3.91	3.91	3.91	3.91	3.91

Pros

Cons

Company has a low return on equity of 11% over the last 3 years.
Debtor days have increased from 107.03 to 116.54days.
Stock is trading at 4.8 times its book value.
The company has delivered a poor profit growth of -16% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.